Form 4 for JNJ Johnson & Johnson
Accepted 2025-02-11 19:41:17 ET · period of report 2025-02-07 · accession 0000200406-25-000013 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2025-02-11 19:41 | 2025-02-07 | JNJ | Taubert Jennifer L | EVP, WWC. Innovative Medicine | M - OptEx | $100.06 | +58.5K | 213.4K | +38% | +$5.85M |
| D | 2025-02-11 19:41 | 2025-02-07 | JNJ | Taubert Jennifer L | EVP, WWC. Innovative Medicine | F - Tax | $153.12 | -47.4K | 165.9K | -22% | -$7.26M |
| D | 2025-02-11 19:41 | 2025-02-07 | JNJ | Taubert Jennifer L | EVP, WWC. Innovative Medicine | M - OptEx | $100.06 | -58.5K | 0 | -100% | -$5.85M |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-02-07 | M | A | 58,504 | $100.06 | 213,355.00 | D | — | — | (F1) Reflects the auto-exercise of options immediately prior to their expiration. |
| 2 | Common | Common Stock | 2025-02-07 | F | D | 47,436 | $153.12 | 165,919.00 | D | — | — | (F2) Shares withheld for payment of the exercise price and taxes in connection with the exercise of the options reported on this Form 4. |
| 3 | Derivative | Employee Stock Options (Right to Buy) | 2025-02-07 | M | D | 58,504 | $100.06 | 0 | D | $100.06 · 2018-02-10 to 2025-02-09 | 58,504 Common Stock | (F1) Reflects the auto-exercise of options immediately prior to their expiration. |